RIPK2 and breast cancer: Erbin, which interacts with Erbb2, is downregulated in HER2-overexpressing breast cancer cells (Liu et al., 2013) and it can form a complex with NOD2 to inhibit RIPK2 activity (Kufer et al., 2006).